Project Grant R01DA061670
- The federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $439,180 to The Johns Hopkins University to investigate the role of dopaminergic neuron-glial interactions in the striatum in the context of HIV infection and substance use disorders. The research aims to deconvolute the complex interplay between HIV, methamphetamine use, and alterations in dopamine signaling pathways, which can contribute...
- The Johns Hopkins University was awarded a $232,625 Project Grant from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) on September 15, 2025. The grant will fund a 2-year study to examine patterns of HIV, hepatitis C, and sexually transmitted infection (STI) co-infection among rural people who inject drugs (PWID) in Cabell County, West Virginia in the context of an ongoing HIV outbreak. The study aims to: 1) identify correlates of co-infection, 2)...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This Project Grant award of $722,917 from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, will fund a 5-year study to evaluate a new approach for dispensing methadone to incarcerated individuals with opioid use disorder (OUD) in three state prison systems. The project aims to support widespread implementation of the hospital/clinic designation, which allows carceral facilities to stock and dispense methadone for OUD treatment, by launching a...
- This $4.9 million project grant from the National Institutes of Health's National Institute on Drug Abuse will support research at The Johns Hopkins University from April 2022 to March 2026. The grant is part of the Drug Abuse and Addiction Research Programs (CFDA 93.279), which aims to develop new knowledge around prevention, diagnosis, treatment and causes of drug abuse and addiction. Specifically, the university will leverage rare longitudinal social and spatial network data along with...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $4,725,000 to the University of California, Los Angeles (UCLA) to develop new dissemination strategies that improve the availability and user-friendliness of research on preventing HIV transmission and effectively treating substance use disorders (SUDs). The project aims to mitigate policy-level barriers and upstream barriers that hinder access...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a comprehensive effort to analyze hundreds of multi-omic datasets related to the impact of substance use disorders (SUD) and HIV on the brain's reward circuitry and neuroinflammation. The $556,432 award, commencing on September 1, 2025, will enable researchers at the University of Maryland, Baltimore to: Assemble a harmonized resource of...
- The National Institute on Drug Abuse (NIDA) awarded a $569,743 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University on July 15, 2025. The grant, titled "Y-SCORCH 2.0: Further Data Mining and Functional Characterization for Single Cell Opioid Responses in the Context of HIV (SCORCH) Program," aims to leverage advanced tools to analyze transcriptomic and epigenetic data from the SCORCH consortium and novel spatial transcriptomic data to...
- This Project Grant award of $182,187 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to characterize spatial access to Medications for Opioid Use Disorder (MOUD) and co-located mental health services, and determine their association with overdose mortality and MOUD treatment uptake and retention. The research will be conducted by The Johns Hopkins University over the project period from August 1, 2025 to July 31, 2030. The...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the effects of opioids on HIV transcription and latency. The $234,000 award to Georgetown University will support research using a novel dual fluorescent and bioluminescent virus called EcoHIV NL4-3 Dual Red to visualize active HIV proviral transcription in microglia and astrocytes. The study will examine the mechanisms by which...
This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and mental health disorders, and HIV and overdose outcomes among people with HIV. The researchers will analyze data from the Johns Hopkins HIV Clinical Cohort and the regional health information exchange to describe patterns of medication-based OUD treatment and examine how co-occurring conditions and concurrent treatments impact HIV outcomes and overdose risk. The award period runs from August 1, 2025 to April 30, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $783.3k | 7/30/25 |